ELI LILLY AND COMPANY Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components
ELI LILLY AND COMPANY (LLY) reported Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components of $7.80 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents · last filed 2015-02-19
- ELI LILLY AND COMPANY defined benefit plan, effect of one percentage point increase on service and interest cost components for fiscal 2014 was $7.80M, a 17.02% decline from fiscal 2013.
- ELI LILLY AND COMPANY defined benefit plan, effect of one percentage point increase on service and interest cost components for fiscal 2013 was $9.40M, a 39.74% decline from fiscal 2012.
- ELI LILLY AND COMPANY defined benefit plan, effect of one percentage point increase on service and interest cost components for fiscal 2012 was $15.60M, a 3.31% increase from fiscal 2011.
- ELI LILLY AND COMPANY defined benefit plan, effect of one percentage point increase on service and interest cost components for fiscal 2011 was $15.10M, a 4.86% increase from fiscal 2010.
| Period end | Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components 12 month |
|---|---|
| 2014-12-31 | $7.80M 10-K · filed 2015-02-19 |
| 2013-12-31 | $9.40M 10-K · filed 2014-02-19 |
| 2012-12-31 | $15.60M 10-K · filed 2013-02-21 |
| 2011-12-31 | $15.10M 10-K · filed 2012-02-24 |
| 2010-12-31 | $14.40M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |